Advertisement
Canada markets closed
  • S&P/TSX

    22,167.03
    +59.95 (+0.27%)
     
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • DOW

    39,807.37
    +47.29 (+0.12%)
     
  • CAD/USD

    0.7386
    -0.0000 (-0.00%)
     
  • CRUDE OIL

    83.11
    -0.06 (-0.07%)
     
  • Bitcoin CAD

    95,932.38
    +1,987.12 (+2.12%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,254.80
    +16.40 (+0.73%)
     
  • RUSSELL 2000

    2,124.55
    +10.20 (+0.48%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • NASDAQ futures

    18,465.00
    -38.75 (-0.21%)
     
  • VOLATILITY

    13.01
    +0.23 (+1.80%)
     
  • FTSE

    7,952.62
    +20.64 (+0.26%)
     
  • NIKKEI 225

    40,322.78
    +154.71 (+0.39%)
     
  • CAD/EUR

    0.6849
    +0.0006 (+0.09%)
     

Better Marijuana Stock: Aphria vs. Aurora Cannabis

Better Marijuana Stock: Aphria vs. Aurora Cannabis

Canadian cannabis sales are continuing to balloon amidst the coronavirus pandemic. The latest data from Statistics Canada show that in June, retail sales topped 201 million Canadian dollars and were up 8% from May's total sales. Despite their historic difficulties in generating cash, paying off debts, and avoiding massive writedowns, Aphria (NASDAQ: APHA) and Aurora Cannabis (NYSE: ACB) could be poised to claim shares of the rapidly expanding marketplace.